Toughest breast cancer may have met its match: Protein inhibitor makes cell susceptible to chemotherapy

Date:

December 8, 2014

Source:

Johns Hopkins Medicine

Summary:

Triple-negative breast cancer is as bad as it sounds. The cells that form these tumors lack three proteins that would make the cancer respond to powerful, customized treatments. Instead, doctors are left with treating these patients with traditional chemotherapy drugs that only show long-term effectiveness in 20 percent of women with triple-negative breast cancer.